Tandem Diabetes Care (NSDQ:TNDM) said today it won FDA 510(k) clearance for an expanded pediatric indication for its t:slim insulin pump, now indicated for use in children 6 and older. The San Diego, Calif.-based company said the expanded indication applies to its current t:slim pump features and that there were no changes made to the existing user […]
tandemdiabetes
Tandem Diabetes to integrate TypeZero’s artificial pancreas tech
Tandem Diabetes Care (NSDQ:TNDM) said today it inked a license agreement with TypeZero Technologies to integrate TypeZero’s artificial pancreas into Tandem’s next-gen t:slim insulin pump. TypeZero’s artificial pancreas technology includes algorithms developed off of initial research conducted at the University of Virginia, and the company said it has been used in more than 28 clinical studies including […]
FDA clears Tandem Diabetes Care’s remote insulin pump updater
Tandem Diabetes Care (NSDQ:TNDM) said today that it won 510(k) clearance from the FDA for a wireless updater for its insulin pumps. San Diego-based Tandem, which makes the t:slim, t:slim G4 and t:flex pumps, said it plans to roll out the device updater in a series of test groups this summer before an expanded launch later in […]
UnitedHealth names Medtronic as preferred insulin pump vendor, dealing blows to Tandem, Insulet, DexCom
Update: Updated with analyst information on Insulet and DexCom, and Insulet’s response. Tandem Diabetes Care (NSDQ:TNDM) shares dropped over 20% after UnitedHealth Group (NYSE:UNH) announced it is making Medtronic (NYSE:MDT) its preferred provider of insulin pumps. Insulet (NSDQ:PODD) and Dexcom Inc. (NSDQ:DXCM) also took a hit with the news, seeing shares drop 10% and 3% respectively The shift will go into […]
Danaher lures ex-Medtronic legal eagle Ellis for GC spot | Personnel Moves
Danaher (NYSE:DHR) said it lured Brian Ellis from Medtronic (NYSE:MDT) to be its new general counsel, replacing Jonathan Graham, who jumpoed ship for Amgen (NSDQ:AMGN) last May. Ellis was general counsel for Medtronic’s restorative therapies group, after stints as GC and chief compliance officer for monitoring solutions at GE Healthcare (NYSE:GE) “Brian brings a wealth of experience leading and […]
Fujifilm Medical Systems names new COO, CMO | Personnel Moves
Fujifilm Holdings (TSE:4901) said its Fujifilm Medical Systems U.S.A. subsidiary lured an Accuray (NSDQ:ARAY) executive and a physician from the University of Southern California to its executive roster effective Sept. 28. The Stamford, Conn.-based company said Johann Fernando, formerly Accuray’s vice president & general manager, was named to be its operations chief. Dr. Diku Mandavia, who has […]
FDA clears Tandem Diabetes t:slim pump with DexCom’s G4 Platinum CGM
The FDA approved a version of the t:slim insulin pump made by Tandem Diabetes Care (NSDQ:TNDM) with an integrated G4 Platinum continuous glucose monitor made by Dexcom Inc. (NSDQ:DXCM), the companies said today. Shipments of the t:slim G4 insulin pump are expected to begin in October, they said. “The t:slim G4 pump combines our intuitive touch-screen interface and bright color display […]
Tandem Diabetes inks Dexcom deal, beats Q2 estimates
Tandem Diabetes Care (NSDQ:TNDM) yesterday reported a couple of wins, announcing a deal to integrate its insulin pumps with Dexcom‘s (NSDQ:DXCM) continuous glucose monitors and beating expectations with its 2nd-quarter results. “Integrating Tandem’s next generation pump platform with Dexcom’s future CGM systems is an important step in aligning our technologies to be used in automated insulin delivery applications,” president […]
Tandem Diabetes launches t:flex insulin pump
Tandem Diabetes plans $60m offering | Medtech funding for the week of March 2, 2015
Diabetes: Tandem closes $60m offering
Tandem Diabetes Care (NSDQ:TNDM) this week said it closed on a previously announced public offering valued at around $60 million.